Navigation Links
Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
Date:9/19/2007

REINACH and BASEL, Switzerland, September 19 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) presented a large body of preclinical and clinical data on its investigational drug iclaprim at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

Iclaprim is a novel late stage investigational antibiotic which exhibits potent activity against Gram-positive bacteria including those resistant to current therapies, e.g., MRSA, VISA, VRSA etc. In three separate efficacy trials, iclaprim has been compared against either linezolid or vancomycin and has consistently shown high clinical cure rates. Moreover, clinical experience to date shows that iclaprim is well-tolerated in patients and volunteers. New data presented at ICAAC included large surveillance studies on recent clinical isolates, quality control and CLSI parameters for susceptibility testing, Phase I pharmacokinetic studies and results from the first pivotal Phase III clinical trial (ASSIST-1).

L-1142: ASSIST-1 data on microbiological efficacy in complicated Skin and Skin Structure Infections (cSSSI). Iclaprim showed high microbiological eradication rates against major cSSSI pathogens, comparable with linezolid (MRSA eradication rates were 84.7% vs. 85.3%, respectively). Additional clinical data on safety and efficacy will be presented in October at the upcoming IDSA meeting in San Diego.

E-902, E-904, E-910, E-911: Four posters presented data on large susceptibility studies against recent clinical isolates: iclaprim was the most active compound tested in a study against community-acquired and nosocomial Staphylococcus aureus (poster E-904) and it showed good activity against streptococci and enterococci.

E-906: Iclaprim exhibited rapid bactericidal activi
'/>"/>

SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. BioRobot MDx standardize your automated protocols in clinical laboratories
5. What patients want: A story of choice, clinical trials & evidence-based medicine
6. ZyStor seeks to raise $15M for clinical trials
7. Prodesse begins clinical trials for flu virus detection
8. ConjuGon raises $3.3 million to fund clinical trials
9. Cancer-fighting agent heads for clinical trials
10. Quintessence cancer treatment chosen for clinical studies
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Z. Yang, Varian, Inc. , ... Bisphenol A (BPA) is a primary raw material used for the ... (4-NP) is a degradation product of alkylphenol ethoxylate detergents used in ... as an additive in plastics that are used for food packaging ...
... Jeffrey J. , Comerford#, Ph.D , ... Monash University, , Clayton campus, , ... Varian Australia, , 679 ... Victoria 3170, Australia , E-mail: fluorescence@varianinc.com , ...
... Purpose , Normal ... using the API 3000 LC/MS/MS System. , ... In recent years, pharmaceutical companies have placed greater importance ... Isomerspecific pharmaceuticals often exhibit increased potency, higher bioavailability and reduced side ...
Cached Biology Technology:Analysis of Phenolic Estrogen Mimics in River Water by Negative Ion Electrospray LC/MS/MS 2Minimizing Photobleaching of Blue Fluorescent Protein (BFP) using , the Varian Cary Eclipse Fluorescence Spectrophotometer 2Minimizing Photobleaching of Blue Fluorescent Protein (BFP) using , the Varian Cary Eclipse Fluorescence Spectrophotometer 3Minimizing Photobleaching of Blue Fluorescent Protein (BFP) using , the Varian Cary Eclipse Fluorescence Spectrophotometer 4Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 2Separation and Quantitation of R and S Enantiomers using Normal Phase Chromatography on an API 3000 LC/MS/MS System 3
(Date:4/16/2014)... of yellow-shouldered bats have been unearthed by scientists at the ... Natural History and described in the open access journal ... genus Sturnira are part of a recent discovery ... the third one still waiting to be officially announced. , ... to contain only 14 species. In the last years closer ...
(Date:4/16/2014)... disease, spinal and bulbar muscular atrophy (SBMA) is a ... weakness and atrophy. Researchers have long considered it to ... the cells in the spinal cord and brainstem that ... published in the April 16, 2014 online issue of ... University of California, San Diego School of Medicine say ...
(Date:4/16/2014)... ability to store memories improves during childhood, associated ... connections with prefrontal and parietal cortices. New research ... regions develop at this crucial time. Eventually, that ... in the transition into and during adolescence and ... Located deep in the middle of the brain, ...
Breaking Biology News(10 mins):Two new species of yellow-shouldered bats endemic to the Neotropics 2Mutant protein in muscle linked to neuromuscular disorder 2How kids' brain structures grow as memory develops 2
... international team of scientists has released data indicating that ... thought because of methane emissions from freshwater areas. ... ecology, evolution and organismal biology department, is part of ... inland waters is higher than previous estimates. ...
... team took a significant step forward in understanding ... pollutants and some other gases, except carbon dioxide. ... with some studies suggesting the self-cleaning power of ... changes, while others suggest greater stability. And what ...
... 2011 Acceleron Pharma, Inc., a biopharmaceutical company developing ... tissues including muscle, bone, fat, red blood cells and ... $1.5 million grant from the Muscular Dystrophy Association to ... (DMD), a disabling neuromuscular disease in which patients experience ...
Cached Biology News:Freshwater methane release changes greenhouse gas equation 2NOAA-led team measures atmosphere's self-cleaning capacity 2NOAA-led team measures atmosphere's self-cleaning capacity 3Acceleron awarded $1.5 million grant from Muscular Dystrophy Association to support ACE-031 2
Agarose Gel Loading Dye Mixture 6X...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Biology Products: